DONO, MARIA
DONO, MARIA
100010 - Dipartimento di Scienze chirurgiche e diagnostiche integrate
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling
2020-01-01 De Luca, G.; Cardinali, B.; Del Mastro, L.; Lastraioli, S.; Carli, F.; Ferrarini, M.; Calin, G. A.; Garuti, A.; Mazzitelli, C.; Zupo, S.; Dono, M.
Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments
2022-01-01 Genova, C.; Tagliabue, E.; Mora, M.; Aloe, T.; Dono, M.; Salvi, S.; Zullo, L.; Barisione, E.
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
2020-01-01 Monti, P.; Lionetti, M.; De Luca, G.; Menichini, P.; Recchia, A. G.; Matis, S.; Colombo, M.; Fabris, S.; Speciale, A.; Barbieri, M.; Gentile, M.; Zupo, S.; Dono, M.; Ibatici, A.; Neri, A.; Ferrarini, M.; Fais, F.; Fronza, G.; Cutrona, G.; Morabito, F.
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors
2020-01-01 Morabito, F.; Gentile, M.; Monti, P.; Recchia, A. G.; Menichini, P.; Skafi, M.; Atrash, M.; De Luca, G.; Bossio, S.; Al-Janazreh, H.; Galimberti, S.; Salah, Z.; Morabito, L.; Mujahed, A.; Hindiyeh, M.; Dono, M.; Fais, F.; Cutrona, G.; Neri, A.; Tripepi, G.; Fronza, G.; Ferrarini, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling | 1-gen-2020 | De Luca, G.; Cardinali, B.; Del Mastro, L.; Lastraioli, S.; Carli, F.; Ferrarini, M.; Calin, G. A.; Garuti, A.; Mazzitelli, C.; Zupo, S.; Dono, M. | |
| Potential application of cryobiopsy for histo-molecular characterization of mediastinal lymph nodes in patients with thoracic malignancies: a case presentation series and implications for future developments | 1-gen-2022 | Genova, C.; Tagliabue, E.; Mora, M.; Aloe, T.; Dono, M.; Salvi, S.; Zullo, L.; Barisione, E. | |
| Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients | 1-gen-2020 | Monti, P.; Lionetti, M.; De Luca, G.; Menichini, P.; Recchia, A. G.; Matis, S.; Colombo, M.; Fabris, S.; Speciale, A.; Barbieri, M.; Gentile, M.; Zupo, S.; Dono, M.; Ibatici, A.; Neri, A.; Ferrarini, M.; Fais, F.; Fronza, G.; Cutrona, G.; Morabito, F. | |
| TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors | 1-gen-2020 | Morabito, F.; Gentile, M.; Monti, P.; Recchia, A. G.; Menichini, P.; Skafi, M.; Atrash, M.; De Luca, G.; Bossio, S.; Al-Janazreh, H.; Galimberti, S.; Salah, Z.; Morabito, L.; Mujahed, A.; Hindiyeh, M.; Dono, M.; Fais, F.; Cutrona, G.; Neri, A.; Tripepi, G.; Fronza, G.; Ferrarini, M. |